Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
Location: United States, Arizona, Tucson
Member count: 201-500
Total raised: $578K
Founded date: 2004
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 08.06.2021 | Grant | $578K | CARB-X | - |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 13.01.2022 | Accelerate... | Accelerate Diagnostics Announc... | - | - | marketscre... |
| 12.01.2021 | Accelerate... | TUCSON, Ariz., Jan. 12, 2021... | - | - | prnewswire... |